Literature DB >> 7838386

Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons.

G Chadi1, Y Cao, R F Pettersson, K Fuxe.   

Abstract

The present study investigates the temporal and spatial changes of the cellular expression of basic fibroblast growth factor messenger RNA and immunoreactivity after a 6-hydroxydopamine-induced lesion in the nigrostriatal dopamine system. In situ hybridization revealed a sustained (from 4 h to two weeks) and strong (300-400% of control, at the peak intervals) increase of basic fibroblast growth factor messenger RNA in the pars compacta of the substantia nigra and the ventral tegmental area ipsilateral to the lesion. A short-lasting increase of basic fibroblast growth factor messenger RNA was observed in he ipsilateral pars reticulata of the substantia nigra (from 4-24 h, 300% of control) and neostriatum (24 h, 180% of control) as well as in the ipsilateral and contralateral hippocampus and neocortex (by 4 h, 200% of control). Brightfield microscopy showed an increased number of putative glial cells expressing the basic fibroblast growth factor messenger RNA signal. Basic fibroblast growth factor immunohistochemistry revealed on control brains the protein in the nuclei of glial cells throughout the forebrain and the midbrain and in the nuclei of neurons of the layer II of the retrosplenial granular cortex, the CA2 region of the hippocampus and the fasciola cinereum as well as in the nuclei of ependymal cells. The injection of 6-hydroxydopamine increased basic fibroblast growth factor immunoreactivity in the nuclei of astrocytes only within the ipsilateral substantia nigra and ventral tegmental area. By 2 h after the drug injection, the density of glial basic fibroblast growth factor-immunoreactive profiles was increased in the pars compacta of the substantia nigra and the ventral tegmental area. The density, size and intensity of the astroglial basic fibroblast growth factor immunoreactive nuclei were increased in the entire substantia nigra and the ventral tegmental area at 72 h, and peaked one week after the 6-hydroxydopamine injection. The saline injection promoted a time-dependent increase in the density of the glial basic fibroblast growth factor immunoreactivity but only in the ipsilateral pars compacta of the substantia nigra. In conclusion, the dopamine cell degeneration may give rise to extracellular signals activating the surrounding astroglia, leading to a sustained increased synthesis of astroglial basic fibroblast growth factor, which may exert neuroprotective action and increase repair on the nigrostriatal dopamine system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7838386     DOI: 10.1016/0306-4522(94)90411-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  On the role of glucocorticoid receptors in brain plasticity.

Authors:  K Fuxe; R Diaz; A Cintra; M Bhatnagar; B Tinner; J A Gustafsson; S O Ogren; L F Agnati
Journal:  Cell Mol Neurobiol       Date:  1996-04       Impact factor: 5.046

2.  Malfunctioning DNA damage response (DDR) leads to the degeneration of nigro-striatal pathway in mouse brain.

Authors:  Michal Kirshner; Ronit Galron; Dan Frenkel; Gil Mandelbaum; Yosef Shiloh; Zhao-Qi Wang; Ari Barzilai
Journal:  J Mol Neurosci       Date:  2011-09-16       Impact factor: 3.444

3.  Ovariectomy of adult rats leads to increased expression of astrocytic basic fibroblast growth factor in the ventral tegmental area and in dopaminergic projection regions of the entorhinal and prefrontal cortex.

Authors:  C Flores; N Salmaso; S Cain; D Rodaros; J Stewart
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

Review 4.  Growth factor regulation of cell growth and proliferation in the nervous system. A new intracrine nuclear mechanism.

Authors:  M K Stachowiak; J Moffett; P Maher; J Tucholski; E K Stachowiak
Journal:  Mol Neurobiol       Date:  1997-12       Impact factor: 5.590

5.  Differential cellular FGF-2 upregulation in the rat facial nucleus following axotomy, functional electrical stimulation and corticosterone: a possible therapeutic target to Bell's palsy.

Authors:  Karen F Coracini; Caio J Fernandes; Almir F Barbarini; César M Silva; Rodrigo T Scabello; Gabriela P Oliveira; Gerson Chadi
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2010-11-09

Review 6.  The importance of molecular histology to study glial influence on neurodegenerative disorders. Focus on recent developed single cell laser microdissection.

Authors:  Gerson Chadi; Jessica Ruivo Maximino; Gabriela Pintar de Oliveira
Journal:  J Mol Histol       Date:  2009-11-01       Impact factor: 2.611

7.  Strain difference in the up-regulation of FGF-2 protein following a neurotoxic lesion of the nigrostriatal pathway.

Authors:  David M Yurek; Anita M Fletcher; Laura E Peters; Wayne A Cass
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

8.  Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist.

Authors:  C Flores; D Rodaros; J Stewart
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

Review 9.  Therapeutic potential of nerve growth factors in Parkinson's disease.

Authors:  T J Collier; C E Sortwell
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

10.  Aortic coarctation hypertension induces fibroblast growth factor-2 immunoreactivity in the stimulated nucleus tractus solitarii.

Authors:  Debora Rejane Fior-Chadi; Tatiana Cristina Nogueira Varella; Jessica Ruivo Maximino; Gerson Chadi
Journal:  J Mol Histol       Date:  2007-06-12       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.